# SODIUM PHENYLACETATE AND SODIUM BENZOATE

NDC: 70511-101
Generic name: sodium phenylacetate and sodium benzoate
Labeler / Manufacturer: MAIA PHARMACEUTICALS, INC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, SOLUTION, CONCENTRATE
Routes: INTRAVENOUS
Marketing started: 20170522

FDA application: ANDA208521

## Active ingredients

- SODIUM BENZOATE: 100 mg/mL
- SODIUM PHENYLACETATE: 100 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"70511-101"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=70511-101
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3529be10-0004-4628-9ca1-67a8acd86b51